Hamburg TranscathEteR Mitral Valve REplacement RegiStry
ConditionMitral Valve Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-110
SponsorUniversitätsklinikum Hamburg-Eppendorf
About this trial
The Hamburg TranscathEteR Mitral Valve REplacement RegiStry (HERMES) is a prospective clinical cohort registry aiming to gather follow-up information on short- and long-term outcome of patients with mitral valve disease that undergo transcatheter mitral valve replacement (TMVR) screening. In particular, long-term durability and function of implanted bioprosteses is of utmost interest for both patients and clinicians. Moreover, this study aimes to investigate and compare the different treatment strategies patients undergo after successful or unsuccessful screening for TMVR.
Eligibility criteria
Qualifiers
Ability to provide written informed consent in accordance with Good Epidemiological Practice and local legislation.
Individuals over the age of 18 years.
Patients with clinically relevant mitral valve disease, who undergo screening for TMVR.
Disqualifiers
Insufficient knowledge of the German language, to understand study documents and interview without translation
Physical or psychological incapability to cooperate in the investigation
Trial design
Treatments tested in this trial
- Not listed
Trial groups
300 Participants
are grouped into 4 trial groupsSponsors and collaborators
Source ClinicalTrials.gov